UTX antibody | knockout validation | Cell Signaling 33510

This is a knockout-validated antibody summary, based on the publication "Loss of KDM6A Activates Super-Enhancers to Induce Gender-Specific Squamous-like Pancreatic Cancer and Confers Sensitivity to BET Inhibitors", as cited below [1]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

Antibody information

Rabbit monoclonal IgG

Company: Cell Signaling

Antibody: UTX

Catalog number: 33510

Summary: Rabbit monoclonal IgG against a recombinant protein surrounding Ala490 of human UTX protein. Reacts with human, mouse, rat, and monkey. Suitable for western blot, immunoprecipitation and immunohistochemistry (paraffin).

Validation Method

Western blot

Sample

Primary murine KrasG12D; Kdm6a null pancreatic cancer cell lines. Cells were solubilized in lysis buffer (25mM Tris-HCl pH 7.6, 200 mM NaCl, 1 mM EDTA, 1% Igepal CA-630, 0.1% Na-Deoxycholate, 0.1% SDS supplemented with a mixture of protease inhibitors).

Figure

Western blots showing the expression of ΔNp63 isoform in Kdm6a null females and a male cell line with concomitant loss of Uty. Please see Figure 3d in the article [1].

References
  1. Andricovich J, Perkail S, Kai Y, Casasanta N, Peng W, Tzatsos A. Loss of KDM6A Activates Super-Enhancers to Induce Gender-Specific Squamous-like Pancreatic Cancer and Confers Sensitivity to BET Inhibitors. Cancer Cell. 2018;33:512-526.e8 pubmed publisher